As a consequence of the initial vaccine shortages in the coronavirus pandemic, the German government is securing vaccine production and supplies for the years ahead. Pharmaceutical producers with appropriate vaccine expertise and capacity were invited to apply for stand-by production agreements with the German government. As joint bidders, Wacker and CordenPharma applied for the stand-by production of vaccines based on messenger ribonucleic acid (mRNA). According to the two companies, their b...